PET imaging for advanced head and neck cancer
Part of Cancer clinical trials.
This trial uses a new imaging agent called [18F]-AraG to see how well it can show head and neck cancers before and after standard radiation therapy. If you have advanced cancer of the throat or voice box that can't be surgically removed, this scan may help doctors understand your cancer better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have advanced cancer in your larynx, hypopharynx, or HPV-negative oropharynx that is stage III or IV and cannot be surgically removed.
- You are scheduled to receive standard treatment with 7 weeks of daily radiation and weekly cisplatin chemotherapy.
- You have a good overall health status (able to carry out daily activities with some help).
- You are willing and able to have two PET scans—one before and one after your treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of PET scan that uses a special tracer (68Ga-FAPI-46) to see if it can better show the extent of head and neck cancers before surgery. It may help doctors plan your treatment more accurately.
This trial uses a special PET scan to look at head and neck cancer cells before treatment. It may help doctors learn more about your cancer and decide if different treatments could work better for you.
This study uses an AI computer method to analyze FDG PET scan images to help tailor (individualize) treatment for people with head and neck squamous cell carcinoma. It aims to improve how doctors plan curative treatment based on your scan.
This study uses PET-CT scans (a type of imaging that highlights active cancer cells) in people with a specific kind of head and neck cancer. The goal is to see how well the first scan identifies tumors that should be checked again with a second scan, to better guide care with radiotherapy.
This study tests a new radioactive tracer called [18F]NOTA-ABY030 to see if it's safe for people with head and neck cancer that may have spread. The tracer lights up cancer cells on a PET scan, helping doctors find tumors more clearly.
This trial studies how well an imaging scan called 18F-FSPG PET shows whether head and neck or lung cancer responds to standard chemoradiotherapy. It may help doctors understand early signs of treatment success or failure.
Hear when a new Locally Advanced Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.